ESC 365 - PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction

ESC Premium Access

PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction

Session: Immuno-inflammation as therapeutic target in heart failure

Topic: Leukocytes, Inflammation, Immunity

Speaker: Doctor L. Michel (Essen, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Lars Michel

University of Duisburg-Essen - West-German Heart and Vascular Center, Essen (Germany)

1 presentation

1 follower

4 more presentations in this session

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

Speaker: Professor P. Ridker (Boston, US)

Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure

Speaker: Professor M. Cunningham (Oklahoma City, US)

Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy

Speaker: Mr M. Podaru (London, GB)

Effects of a selective small-molecule formyl peptide receptor 2 agonist on post myocardial inflammation and left ventricular structure-function relationships

Speaker: Doctor R. Garcia (Princeton, US)

Access the full session

Immuno-inflammation as therapeutic target in heart failure

Speakers: Doctor L. Michel, Professor P. Ridker, Professor M. Cunningham, Mr M. Podaru, Doctor R. Garcia

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources